2-(substituted imino)-thiazolidines and process for the preparation
thereof
    1.
    发明授权
    2-(substituted imino)-thiazolidines and process for the preparation thereof 失效
    2-(取代的亚氨基) - 噻唑啉及其制备方法

    公开(公告)号:US5240918A

    公开(公告)日:1993-08-31

    申请号:US857067

    申请日:1992-03-24

    IPC分类号: C07D277/18

    CPC分类号: C07D277/18

    摘要: The invention relates to new 2-(substituted imino)-thiazolidines, a process for the preparation thereof, pharmaceutical compositions comprising the same, the use of the said 2-(substituted imino)thiazolidines for the treatment of diseases and for the preparation of pharmaceutical compositions suitable for the treatment of diseases.The new 2-(substituted imino)-thiazolidine derivatives provided by the present invention correspond to the general formula (I), ##STR1## wherein R.sup.1 and R.sup.2 each represent halogen, nitro, C.sub.1-4 alkoxy or C.sub.1-4 alkyl, which latter may optionally carry one or more halogen substituent(s),R.sup.3 and R.sup.4 each represent hydrogen or C.sub.1-4 alkyl,Z denotes oxygen, sulfur or imino, which latter is substituted by a C.sub.1-6 alkyl or a C.sub.1-6 alkenyl group,R.sup.5 stands for hydrogen, C.sub.1-4 alkyl, C.sub.1-4 alkylthio or a group or the formula --NH--R, wherein R represents C.sub.1-6 alkyl, aryl, aralkyl or C.sub.1-6 alkenyl optionally carrying a halogen or a di-(C.sub.1-4 alkyl)-amino substituent; orZ and R.sup.5 together stand for a trivalent nitrogen atom, with the proviso that if Z denotes a substituted imino group, R.sup.5 stands for C.sub.1-4 alkylthio, and if R.sup.5 is C.sub.1-4 alkylthio, Z represents a substituted imino, and with the further proviso that if Z denotes sulfur, R.sup.5 is other than hydrogen or C.sub.1-4 alkyl,and possess valuable antianginal and analgesic properties.

    摘要翻译: 本发明涉及新的2-(取代的亚氨基) - 噻唑烷,其制备方法,包含该方法的药物组合物,所述2-(取代的亚氨基)噻唑烷用于治疗疾病和用于制备药物 适用于治疗疾病的组合物。 本发明提供的新的2-(取代亚氨基) - 噻唑烷衍生物对应于通式(I),其中R 1和R 2各自表示卤素,硝基,C 1-4烷氧基或C 1-4烷基 ,其可以任选地带有一个或多个卤素取代基,R 3和R 4各自表示氢或C 1-4烷基,Z表示氧,硫或亚氨基,后者被C 1-6烷基或C 1-6 烯基,R5代表氢,C1-4烷基,C1-4烷硫基或基团-NH-R,其中R表示C1-6烷基,芳基,芳烷基或任选携带卤素或 二(C 1-4烷基) - 氨基取代基; 或Z和R5一起代表三价氮原子,条件是如果Z表示取代的亚氨基,则R5表示C1-4烷硫基,如果R5是C1-4烷硫基,则Z表示取代的亚氨基,并且与 进一步的条件是,如果Z表示硫,R5不是氢或C1-4烷基,并且具有有价值的抗心绞痛和止痛特性。

    Aminopropanol derivatives, process for their preparation and
pharmaceutical compositions comprising the same
    4.
    发明授权
    Aminopropanol derivatives, process for their preparation and pharmaceutical compositions comprising the same 失效
    氨基丙醇衍生物,其制备方法和包含其的药物组合物

    公开(公告)号:US5234934A

    公开(公告)日:1993-08-10

    申请号:US876091

    申请日:1992-04-30

    摘要: The invention relates to novel racemic or optically active aminopropanol derivatives of formula I ##STR1## wherein R and R.sup.1 are independently hydrogen atom, halogen atom, lower alkoxy, or together represent a methylene dioxy group,R.sup.2 and R.sup.3 together represent a chemical bond or independently stand for a hydrogen atom,R.sup.4 and R.sup.5 are independently hydrogen atom, C.sub.3-7 cycloalkyl group or straight or branched, saturated or unsaturated C.sub.1-12 alkyl group optionally substituted by one or more dialkyl-aminoalkyl, dimethoxyphenyl or phenyl groups, orR.sup.4 and R.sup.5 together with the adjacent nitrogen atom form a 4 to 7 membered ring optionally comprising an oxygen, sulfur or a further nitrogen atom, which ring is optionally substituted by a phenyl, benzyl or C.sub.1-3 alkyl group and the said substituents may carry a hydroxyl group, one or two methoxy groups, halogen atoms or trifluoromethyl groups, orR.sup.4 and R.sup.5 together with the adjacent nitrogen atom form a piperidine ring which is optionally substituted by a phenyl or benzyl group and, if desired, it comprises a double bond,R.sup.6 stands for hydrogen atom or benzoyl group, andn represents an integer from 3 to 6,acid-addition salts and quaternary ammonium derivatives thereof.Further the invention relates to processes for preparing these compounds.The compounds of the invention exert cardiac circulation controlling and/or improving, central nervous system tranquillizing and/or digestive system irregulations improving effects.

    摘要翻译: 本发明涉及式I的新型外消旋或光学活性氨基丙醇衍生物其中R和R 1独立地为氢原子,卤素原子,低级烷氧基或一起代表亚甲基二氧基,R2和R3一起表示化学键或 独立地代表氢原子,R4和R5独立地是氢原子,C3-7环烷基或任选被一个或多个二烷基氨基烷基,二甲氧基苯基或苯基取代的直链或支链,饱和或不饱和的C 1-12烷基,或R 4 和R5与相邻的氮原子一起形成任选地包含氧,硫或另外的氮原子的4至7元环,该环任选被苯基,苄基或C 1-3烷基取代,所述取代基可以携带 羟基,一个或两个甲氧基,卤素原子或三氟甲基,或R4和R5与相邻的氮原子一起形成哌啶环,其任选地是 由苯基或苄基构成,如果需要,它包含双键,R6代表氢原子或苯甲酰基,n代表3-6的整数,其酸加成盐和季铵衍生物。 本发明还涉及制备这些化合物的方法。 本发明的化合物发挥心脏循环控制和/或改善,中枢神经系统镇定和/或消化系统不调节改善作用。

    Triazolyl thioamide derivates
    7.
    发明授权
    Triazolyl thioamide derivates 失效
    三唑基硫代酰胺衍生物

    公开(公告)号:US5276030A

    公开(公告)日:1994-01-04

    申请号:US755219

    申请日:1991-09-09

    CPC分类号: C07D249/14

    摘要: The invention relates to novel triazolyl thioamides of the general formula (I), ##STR1## wherein Q represents hydrogen or a heterocyclic group optionally bearing one or more C.sub.1-4 alkyl substituent(s), or a group of the formula SR.sup.1, whereinR.sup.1 stands for straight or branched chained alkyl group comprising 1 to 6 carbon atom(s), or a group of the formula NR.sup.2 R.sup.3, whereinR.sup.2 and R.sup.3 each represent hydrogen, straight or branched chained C.sub.1-4 alkyl or C.sub.2-6 alkenyl group,Y denotes C.sub.1-4 alkyl bearing one or more hydroxyl or C.sub.1-4 alkoxy substituent(s), phenyl-(C.sub.1-4 alkyl) optionally bearing on the phenyl ring one or more C.sub.1-4 alkoxy group(s), or phenoxy-(C.sub.1-4 alkyl) optionally substituted on the phenyl ring by a C.sub.1-4 alkyl bearing a heterocyclic group containing a nitrogen atom, with the proviso that if Q represents methylthio, dimethylamino, piperidino or morpholino, Y is other than benzyl,and pharmaceutically acceptable acid additional salts thereof.Furthermore the invention relates to a process for preparing these compounds.The compounds according to the invention possess tranquillant, antidepressant, spasmolytic, antiinflammatory, analgesic and antiperistaltic effects.

    摘要翻译: 本发明涉及通式(I)的新型三唑基硫代酰胺,其中Q表示氢或任选带有一个或多个C 1-4烷基取代基的杂环基或式SR1的基团,其中R 1 代表包含1至6个碳原子的直链或支链烷基或式NR2R3基团,其中R2和R3各自表示氢,直链或支链C 1-4烷基或C 2-6烯基,Y 表示具有一个或多个羟基或C 1-4烷氧基取代基的C 1-4烷基,任选地在苯环上带有一个或多个C 1-4烷氧基的苯基 - (C 1-4烷基)或苯氧基 - ( C 1-4烷基),其任选在苯环上被带有含氮原子的杂环基的C 1-4烷基取代,条件是如果Q表示甲硫基,二甲基氨基,哌啶子基或吗啉代,则Y不是苄基, 其酸加成盐。 此外,本发明涉及一种制备这些化合物的方法。 根据本发明的化合物具有镇静,抗抑郁,解痉,抗炎,止痛和抗静脉作用。

    Triazolyl thioamide derivates
    8.
    发明授权
    Triazolyl thioamide derivates 失效
    三唑氧化物衍生物

    公开(公告)号:US5175163A

    公开(公告)日:1992-12-29

    申请号:US617126

    申请日:1990-11-21

    CPC分类号: C07D249/14

    摘要: The invention relates to novel triazolyl thioamides of the general formula (I), ##STR1## wherein Q represents hydrogen or a heterocyclic group optionally bearing one or more C.sub.1-4 alkyl substituent(s), or a group of the formula SR.sup.1, whereinR.sup.1 stands for straight or branched chained alkyl group comprising 1 to 6 carbon atom(s), or a group of the formula NR.sup.2 R.sup.3, whereinR.sup.2 and R.sup.3 each represent hydrogen, straight or branched chained C.sub.1-4 alkyl or C.sub.2-6 alkenyl group,Y denotes C.sub.1-4 alkyl optionally bearing one or more hydroxyl or C.sub.1-4 alkoxy substituent(s), phenyl-(C.sub.1-4 alkyl) optionally bearing on the phenyl ring one or more C.sub.1-4 alkoxy group(s), or phenoxy-(C.sub.1-4 alkyl) optionally substituted on the phenyl ring by a C.sub.1-4 alkyl bearing a heterocyclic group containing a nitrogen atom,and pharmaceutically acceptable acid addition salts thereof.Furthermore the invention relates to a process for preparing these compounds.The compounds according to the invention possess tranquillant, antidepressant, spacmolytic, antiinflammatory, analgesic and antiperistaltic effects.

    摘要翻译: 本发明涉及通式(I)的新型三唑基硫代酰胺,其中Q表示氢或任选带有一个或多个C 1-4烷基取代基的杂环基或式SR 1的基团 其中R1代表包括1至6个碳原子的直链或支链烷基或式NR2R3基团,其中R2和R3各自表示氢,直链或支链C 1-4烷基或C 2-6烯基 基团,Y表示任选带有一个或多个羟基或C 1-4烷氧基取代基的C 1-4烷基,任选地在苯环上带有一个或多个C 1-4烷氧基的苯基 - (C 1-4烷基) 或在苯环上被含有含有氮原子的杂环基的C 1-4烷基任选取代的苯氧基 - (C 1-4烷基)及其药学上可接受的酸加成盐。 此外,本发明涉及一种制备这些化合物的方法。 根据本发明的化合物具有镇静,抗抑郁,间质,抗炎,止痛和抗静脉作用。